Compare OPHC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPHC | DRIO |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 60.6M |
| IPO Year | 2012 | 2013 |
| Metric | OPHC | DRIO |
|---|---|---|
| Price | $5.73 | $7.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.50 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 37.2K | 9.0K |
| Earning Date | 04-24-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | 0.20 | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | $17,095.98 | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $29.40 | ★ $5.40 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $3.91 | $0.38 |
| 52 Week High | $5.90 | $17.74 |
| Indicator | OPHC | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.69 | 51.48 |
| Support Level | $5.40 | $6.13 |
| Resistance Level | $5.90 | $9.24 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 55.26 | 60.10 |
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. The services provided by the bank include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, borrowings, repayment of loans, money market deposit accounts, debit cards, automated teller machines, and other bank related services.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.